UCB's Neupro available again in the EU
This article was originally published in Scrip
Executive Summary
UCB is making available again its transdermal patch, Neupro (rotigotine), in the EU, following approval by the European Commission of last month's positive opinion from the CHMP (scripnews.com, June 1st, 2009). It is indicated for the treatment of Parkinson's disease and a new indication, restless legs syndrome.